Scott K. Winiecki, MD

Team Lead, Safe Use Initiative

Professional Affairs and Stakeholder Engagement Staff

Center for Drug Evaluation and Research

US Food and Drug Administration

Erin Hopwood

Principal Analyst, Legislative Counsel

Maryland Department of Legislative Services

Sarah Bacon, PhD

Lead Behavioral Scientist

Prescription Drug Overdose State Support Team

Department of Unintentional Injury Prevention

Centers for Disease Control and Prevention (CDC)

Rebecca Andrews, MD

General Medicine Clinic Director

Associate Program Director, Categorical Internal Medicine

University of Connecticut Health Center

Edwin Salsitz, MD

Attending Physician – Division of Chemical Dependency

Assitant Professor of Psychiatry

Mount Sinai Beth Israel Medical Center

Brian Rucker

Director of Compliance

Retired DEA Supervisor

Independent Pharmacy Cooperative

Kevin Chamberlin, PharmD, FASCP

Associate Clinical Professor & Assistant Department Head, Pharmacy Practice

Residency Program Director

University of Connecticut School of Pharmacy, UConn Health

SreRam Kuy, MD, MHS, FACS

Associate Chief of Staff

Michael E. DeBakey VA Medical Center

Elizabeth Collier

State Opioid Treatment Authority

Division of Care and Treatment Services

Bureau of Prevention Treatment and Recovery

Wisconsin Department of Health Services

Monica Morgan, PharmD

System Director, Clinical Pharmacy Services

Ochsner Health System

John J. Dreyzehner, MD, MPH

Commissioner of Health

State of Tennessee

Sam S. Torbati, MD, FAAEM, FACEP

Associate Professor of Emergency Medicine

Co-Chairman and Medial Director

Ruth and Harry Roman Emergency Department

Cedars-Sinai Medical Center

Lisa Burgess, MD

Chief Medical Officer

Maryland Department of Health

Dr. Bob Hinds, DBA, ACATA

Corporate Director of Opiate Addiction Treatment Strategy

Bradford Health Services

John Roehm, PharmD

Inpatient Clinical Pharmacy Specialist

Department of Veteran’s Affairs Boston

Jamelia Hand

Chief Executive Officer

Vantage Clinical Consulting LLC